It is not clear whether Carboxymethyl Starch Sodium Solution and Transfer Factor are in conflict; both have immunomodulatory effects and need to be used as prescribed. Carboxymethyl starch sodium solution belongs to the immunomodulatory drugs. It can be used for pediatric recurrent respiratory tract infections, as well as the resulting induced bronchial asthma. Adverse reactions to this product can be seen in the form of increased frequency and pasty stools that may occur during the initial period of administration. Contraindications to this product are unclear. Common dosage forms of transfer factors include oral solutions and capsules. It is also an immunomodulatory drug. It can enhance or inhibit the function of humoral and cellular immunity. It is used as an adjunctive treatment for difficult-to-control viral and mycobacterial intracellular infections such as herpes zoster and Candida albicans infections; it is also used as an adjunctive therapeutic agent for malignant tumors. It is contraindicated in people who are allergic to the product. Adverse effects of the drug are not known. The instructions for both Carboxymethyl Starch Sodium Solution and Transfer Factor state that studies related to drug interactions are unclear. Therefore, it is not clear whether drug interactions will occur between the two. The drug should be used rationally under the guidance of a doctor.